eicosapentaenoic acid ethyl ester has been researched along with Mental Disorders in 2 studies
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "New treatments for psychiatric disorders are urgently required." | 2.41 | A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). ( Horrobin, DF, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mocking, RJT | 1 |
| Assies, J | 1 |
| Ruhé, HG | 1 |
| Schene, AH | 1 |
| Horrobin, DF | 1 |
2 reviews available for eicosapentaenoic acid ethyl ester and Mental Disorders
| Article | Year |
|---|---|
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.
Topics: Eicosapentaenoic Acid; Fatty Acids; Humans; Hypothalamo-Hypophyseal System; Inflammation; Mental Dis | 2018 |
A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E).
Topics: Animals; Eicosapentaenoic Acid; Humans; Lipids; Mental Disorders; Psychotropic Drugs; Technology, Ph | 2002 |